Epidemiology of clinically isolated methicillin-resistant Staphylococcus aureus (MRSA) and its susceptibility to linezolid and vancomycin in Egypt: a systematic review with meta-analysis

• Published in: BMC infectious diseases Vol. 23; no. 1; pp. 263 - 15
• Main Authors: Azzam, Ahmed, Khaled, Heba, Mosa, Maha, Refaey, Neveen, AlSaifi, Mohammed, Elsisi, Sarah, Elagezy, Fatma Khaled, Mohsen, May
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 26.04.2023; BioMed Central; BMC
• Subjects: Analysis; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Antibiotics; Antimicrobial agents; Bacterial Proteins - genetics; Cefoxitin; Cefoxitin - therapeutic use; Cefoxitin disc diffusion; Clinical isolates; Diffusion; Diffusion rate; Disease control; Disease susceptibility; Dosage and administration; Drug resistance; Drug resistance in microorganisms; Egypt; Egypt - epidemiology; Epidemiology; Health aspects; Hospital costs; Humans; Infectious diseases; Linezolid; Linezolid - pharmacology; Linezolid - therapeutic use; Literature reviews; MecA protein; Medical personnel; Meta-analysis; Methicillin; Methicillin-resistant Staphylococcus aureus; Methicillin-Resistant Staphylococcus aureus - genetics; Microbial Sensitivity Tests; Morbidity; Mortality; MRSA; Nosocomial infection; Oxacillin; Oxacillin disc diffusion; Penicillin; Penicillin-Binding Proteins - genetics; Prevalence; Prevalence studies (Epidemiology); Prevention; Prohibition; Public health; Risk factors; Sensitivity analysis; Staphylococcal Infections - drug therapy; Staphylococcus aureus; Staphylococcus aureus infections; Staphylococcus infections; Statistical analysis; Subgroups; Systematic review; Vancomycin; Vancomycin - pharmacology; Vancomycin - therapeutic use; Egypt; United Kingdom > UK; Linezolid; Oxacillin disc diffusion; Prevalence; Cefoxitin disc diffusion; Methicillin-resistant Staphylococcus aureus; Egypt; MRSA; Vancomycin; Epidemiology; PCR

Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality worldwide. For the establishment of national strategies to combat MRSA infection in each country, accurate and current statistics characterizing the epidemiology of MRSA are e...